These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 1587268)
1. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Stubbs MT; Oschkinat H; Mayr I; Huber R; Angliker H; Stone SR; Bode W Eur J Biochem; 1992 May; 206(1):187-95. PubMed ID: 1587268 [TBL] [Abstract][Full Text] [Related]
2. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity. Ni F; Zhu Y; Scheraga HA J Mol Biol; 1995 Oct; 252(5):656-71. PubMed ID: 7563081 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure of fibrinogen-Aalpha peptide 1-23 (F8Y) bound to bovine thrombin explains why the mutation of Phe-8 to tyrosine strongly inhibits normal cleavage at Arg-16. Malkowski MG; Martin PD; Lord ST; Edwards BF Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):815-22. PubMed ID: 9307032 [TBL] [Abstract][Full Text] [Related]
4. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin. Maurer MC; Peng JL; An SS; Trosset JY; Henschen-Edman A; Scheraga HA Biochemistry; 1998 Apr; 37(17):5888-902. PubMed ID: 9558322 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of oligopeptide chloromethanes to investigate extended binding regions of proteinases: application to the interaction of fibrinogen with thrombin. Angliker H; Shaw E; Stone SR Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):261-6. PubMed ID: 8503855 [TBL] [Abstract][Full Text] [Related]
6. Structures of thrombin complexes with a designed and a natural exosite peptide inhibitor. Qiu X; Yin M; Padmanabhan KP; Krstenansky JL; Tulinsky A J Biol Chem; 1993 Sep; 268(27):20318-26. PubMed ID: 8376390 [TBL] [Abstract][Full Text] [Related]
7. Structure of the Ser195Ala mutant of human alpha--thrombin complexed with fibrinopeptide A(7--16): evidence for residual catalytic activity. Krishnan R; Sadler JE; Tulinsky A Acta Crystallogr D Biol Crystallogr; 2000 Apr; 56(Pt 4):406-10. PubMed ID: 10739913 [TBL] [Abstract][Full Text] [Related]
8. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures. Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407 [TBL] [Abstract][Full Text] [Related]
9. The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. Martin PD; Robertson W; Turk D; Huber R; Bode W; Edwards BF J Biol Chem; 1992 Apr; 267(11):7911-20. PubMed ID: 1560020 [TBL] [Abstract][Full Text] [Related]
10. Release of fibrinopeptides by the slow and fast forms of thrombin. Vindigni A; Di Cera E Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191 [TBL] [Abstract][Full Text] [Related]
11. The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen. Krarup A; Gulla KC; Gál P; Hajela K; Sim RB Biochim Biophys Acta; 2008 Sep; 1784(9):1294-300. PubMed ID: 18456010 [TBL] [Abstract][Full Text] [Related]
12. Peptide mimetics of the thrombin-bound structure of fibrinopeptide A. Nakanishi H; Chrusciel RA; Shen R; Bertenshaw S; Johnson ME; Rydel TJ; Tulinsky A; Kahn M Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1705-9. PubMed ID: 1542664 [TBL] [Abstract][Full Text] [Related]
13. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues. Martin PD; Malkowski MG; DiMaio J; Konishi Y; Ni F; Edwards BF Biochemistry; 1996 Oct; 35(40):13030-9. PubMed ID: 8855938 [TBL] [Abstract][Full Text] [Related]
14. The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors. Le Bonniec BF; Guinto ER; MacGillivray RT; Stone SR; Esmon CT J Biol Chem; 1993 Sep; 268(25):19055-61. PubMed ID: 8395526 [TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6. Zdanov A; Wu S; DiMaio J; Konishi Y; Li Y; Wu X; Edwards BF; Martin PD; Cygler M Proteins; 1993 Nov; 17(3):252-65. PubMed ID: 8272424 [TBL] [Abstract][Full Text] [Related]
16. The fibrinogen sequences that interact with thrombin. Binnie CG; Lord ST Blood; 1993 Jun; 81(12):3186-92. PubMed ID: 8507860 [No Abstract] [Full Text] [Related]
17. Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker. Slon-Usakiewicz JJ; Purisima E; Tsuda Y; Sulea T; Pedyczak A; Féthière J; Cygler M; Konishi Y Biochemistry; 1997 Nov; 36(44):13494-502. PubMed ID: 9354617 [TBL] [Abstract][Full Text] [Related]
18. Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms. Priestle JP; Rahuel J; Rink H; Tones M; Grütter MG Protein Sci; 1993 Oct; 2(10):1630-42. PubMed ID: 8251938 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65). Schmitz T; Rothe M; Dodt J Eur J Biochem; 1991 Jan; 195(1):251-6. PubMed ID: 1991472 [TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. Grütter MG; Priestle JP; Rahuel J; Grossenbacher H; Bode W; Hofsteenge J; Stone SR EMBO J; 1990 Aug; 9(8):2361-5. PubMed ID: 2369893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]